905307-04-2 Usage
Uses
Used in Organic Synthesis:
(1-Ethyl-1H-pyrazol-4-yl)-methanol is used as a building block in organic synthesis for the creation of various biologically active molecules. Its unique structure and functional groups make it a valuable component in the development of new chemical entities with potential applications in various fields.
Used in Pharmaceutical Research:
In pharmaceutical research, (1-Ethyl-1H-pyrazol-4-yl)-methanol serves as an intermediate for the synthesis of a wide range of biologically active compounds. Its presence in the molecular structure of these compounds contributes to their potential therapeutic effects, making it an essential component in drug discovery and development.
Used in Agrochemicals Manufacturing:
(1-Ethyl-1H-pyrazol-4-yl)-methanol is also utilized as an intermediate in the manufacturing of agrochemicals. Its versatile structure allows for the synthesis of various agrochemicals with potential applications in crop protection, pest control, and other agricultural practices.
Used in Pharmaceutical Manufacturing:
In the pharmaceutical industry, (1-Ethyl-1H-pyrazol-4-yl)-methanol plays a crucial role as an intermediate in the production of various pharmaceuticals. Its ability to be incorporated into the molecular structure of these drugs contributes to their efficacy and therapeutic potential, making it an indispensable component in the development of new medications.
Check Digit Verification of cas no
The CAS Registry Mumber 905307-04-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,0,5,3,0 and 7 respectively; the second part has 2 digits, 0 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 905307-04:
(8*9)+(7*0)+(6*5)+(5*3)+(4*0)+(3*7)+(2*0)+(1*4)=142
142 % 10 = 2
So 905307-04-2 is a valid CAS Registry Number.
905307-04-2Relevant articles and documents
1-((1H-PYRAZOL-4-YL)METHYL)-3-(PHENYL)-1,3-DIHYDRO-2H-IMIDAZOL-2-ONE DERIVATIVES AND RELATED COMPOUNDS AS GPR139 ANTAGONISTS FOR THE TREATMENT OF E.G. DEPRESSION
-
Paragraph 000383-000384; 000422-000423, (2021/11/26)
The present invention refers to compounds of formula (I). The present invention also relates to compounds of formula (I) for use as G Protein coupled Receptor 139 (GPR139) antagonists in methods of medical treatment of e.g. depression, Alzheimer's disease
3-((1H-PYRAZOL-4-YL)METHYL)-6'-(PHENYL)-2H-(1,2'-BIPYRIDIN)-2-ONE DERIVATIVES AND RELATED COMPOUNDS AS GPR139 ANTAGONISTS FOR USE IN A METHOD OF TREATMENT OF E.G. DEPRESSION
-
Paragraph 000331; 000340; 000342-000343; ..., (2021/11/26)
The present invention refers to compounds of formula (I). The present invention also relates to compounds of formula (I) for use as G Protein coupled Receptor 139 (GPR139) antagonists in methods of medical treatment of e.g. depression, Alzheimer's disease
PYRAZOLO[1,5a]PYRIMIDINE DERIVATIVES AS IRAK4 MODULATORS
-
Page/Page column 700; 701, (2017/07/14)
Compounds of Formula (0), Formula (I), and Formula (II) and methods of use as Interleukin-1 Receptor Associated Kinase (IRAK4) inhibitors are described herein.
OPTICALLY ACTIVE TETRAHYDRONAPHTHALENE DERIVATIVE
-
Page/Page column 16, (2010/11/28)
A compound represented by the following formula (I), a pharmacologically acceptable salt thereof or a hydrate thereof or a solvate thereof, which shows not only a C5a receptor antagonistic activity but also high activity in the biological availability, as